0.9009
price down icon1.92%   -0.0176
after-market Handel nachbörslich: .90 -0.0009 -0.10%
loading

Ocugen Inc Aktie (OCGN) Neueste Nachrichten

pulisher
01:55 AM

Ocugen Announces European Medicines Agency Grants Orphan - GlobeNewswire

01:55 AM
pulisher
Nov 20, 2024

Ocugen reports positive data for OCU400, OCU410 - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Ocugen Inc. stock rises Wednesday, outperforms market - MarketWatch

Nov 20, 2024
pulisher
Nov 20, 2024

Ocugen announces EMA granted orphan medicinal product designation for OCU410ST - TipRanks

Nov 20, 2024
pulisher
Nov 20, 2024

Ocugen Advances Gene Therapy and Financial Strategies in Q3 2024 - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Ocugen's Eye Disease Drug Shows 84% Lesion Reduction, Receives EMA Orphan Status | OCGN Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 19, 2024

Ocugen Inc. stock falls Tuesday, underperforms market - MarketWatch

Nov 19, 2024
pulisher
Nov 19, 2024

Ocugen announces positive preliminary data from OCU410 Phase 1 clinical trial for geographic atrophy - Ophthalmology Times

Nov 19, 2024
pulisher
Nov 19, 2024

Ocugen announces preliminary efficacy, safety data from Phase 1/2 OCU410 trial - TipRanks

Nov 19, 2024
pulisher
Nov 19, 2024

Ocugen Announces Compelling Preliminary Data for OCU410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration - Ocugen

Nov 19, 2024
pulisher
Nov 19, 2024

Ocugen Announces Compelling Preliminary Data for OCU410—a - GlobeNewswire

Nov 19, 2024
pulisher
Nov 19, 2024

Ocugen's Eye Treatment Shows 21% Disease Slowdown in Phase 1 Trial Data | OCGN Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 18, 2024

Ocugen Inc. stock falls Monday, underperforms market - MarketWatch

Nov 18, 2024
pulisher
Nov 18, 2024

OCGN Stock: Can New Leadership Save This Biotech Company? - TipRanks

Nov 18, 2024
pulisher
Nov 15, 2024

Ocugen Inc. stock falls Friday, underperforms market - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

Ocugen Appoints Ramesh Ramachandran as Financial Officer - TipRanks

Nov 15, 2024
pulisher
Nov 15, 2024

Dow Jones Transportations Average (DOWT) QuotePress Release - The Globe and Mail

Nov 15, 2024
pulisher
Nov 15, 2024

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Nov 15, 2024
pulisher
Nov 15, 2024

TSX 60 Index (TXSX) QuotePress Release - The Globe and Mail

Nov 15, 2024
pulisher
Nov 15, 2024

Nasdaq Health Care Index (IXHC) QuotePress Release - The Globe and Mail

Nov 15, 2024
pulisher
Nov 15, 2024

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Nov 15, 2024
pulisher
Nov 15, 2024

Microsoft Corp (MSFT-Q) QuotePress Release - The Globe and Mail

Nov 15, 2024
pulisher
Nov 15, 2024

Ocugen: Q3 Earnings Snapshot - New Haven Register

Nov 15, 2024
pulisher
Nov 14, 2024

Ocugen, Inc. (OCGN) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

Ocugen Inc. stock rises Thursday, outperforms market - MarketWatch

Nov 14, 2024
pulisher
Nov 14, 2024

Ocugen (OCGN) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

SEC Form 10-Q filed by Ocugen Inc. - Quantisnow

Nov 14, 2024
pulisher
Nov 14, 2024

HC Wainwright Has Pessimistic View of Ocugen FY2024 Earnings - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Ocugen Inc. stock falls Wednesday, underperforms market - MarketWatch

Nov 13, 2024
pulisher
Nov 12, 2024

Ocugen to Present Innovations at Nasdaq Clinical Showcase - TipRanks

Nov 12, 2024
pulisher
Nov 11, 2024

Navigating 4 Analyst Ratings For Ocugen - Benzinga

Nov 11, 2024
pulisher
Nov 11, 2024

Ocugen (NASDAQ:OCGN) Given Buy Rating at HC Wainwright - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Chardan Capital Reaffirms Buy Rating for Ocugen (NASDAQ:OCGN) - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Earnings call: Ocugen outlines progress in ophthalmology trials, financials - Investing.com

Nov 09, 2024
pulisher
Nov 09, 2024

Earnings call: Ocugen outlines progress in ophthalmology trials, financials By Investing.com - Investing.com Australia

Nov 09, 2024
pulisher
Nov 09, 2024

Ocugen, Inc. (NASDAQ:OCGN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024
pulisher
Nov 09, 2024

Ocugen Inc (OCGN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance

Nov 09, 2024
pulisher
Nov 08, 2024

Ocugen: Progress in Gene Therapy and Financial Outlook - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Ocugen (OCGN) Q3 2024 Earnings Call Transcript - The Motley Fool

Nov 08, 2024
pulisher
Nov 08, 2024

OCGN Earnings: Ocugen’s Q3 Results Disappoint - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Ocugen receives $30M credit facility to fund, allocate resources across company - Pennsylvania Business Report

Nov 08, 2024
pulisher
Nov 08, 2024

Ocugen reports Q3 revenue $1.136M, consensus $300,000 - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Ocugen Provides Business Update with Third Quarter 2024 Financial Results - Ocugen

Nov 08, 2024
pulisher
Nov 08, 2024

Ocugen Secures $65M Financing, Extends Runway to 2026 as Gene Therapy Trials Advance | OCGN Stock News - StockTitan

Nov 08, 2024
pulisher
Nov 08, 2024

Ocugen (NASDAQ:OCGN) soars 19% this week, taking one-year gains to 193% - Simply Wall St

Nov 08, 2024
pulisher
Nov 07, 2024

A Preview Of Ocugen's Earnings - Benzinga

Nov 07, 2024
pulisher
Nov 07, 2024

Ocugen Secures $30 Million In Debt Funding - citybiz

Nov 07, 2024
pulisher
Nov 07, 2024

Ocugen Secures $30 Million in Debt Funding - Ocugen

Nov 07, 2024
pulisher
Nov 07, 2024

Ocugen, Inc. Secures $30 Million in Debt Funding - Marketscreener.com

Nov 07, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):